Novartis AG
ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE
Last updated:
Abstract:
The present invention relates to monoclonal antibodies binding to human angiopoietin-like 4 protein (hereinafter, sometimes referred to as "ANGPTL4"), and pharmaceutical compositions and methods of treatment comprising the same.
Status:
Application
Type:
Utility
Filling date:
21 Mar 2022
Issue date:
7 Jul 2022